# Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

> **NCT05264753** · — · RECRUITING · sponsor: **Occlutech International AB** · enrollment: 255 (estimated)

## Conditions studied

- Patent Ductus Arteriosus

## Interventions

- **DEVICE:** Occlutech® PDA Occluder

## Key facts

- **NCT ID:** NCT05264753
- **Lead sponsor:** Occlutech International AB
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-20
- **Primary completion:** 2029-10-25
- **Final completion:** 2029-11-25
- **Target enrollment:** 255 (ESTIMATED)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05264753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05264753, "Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05264753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*